MILO/ENGOT-ov11: Binimetinib Versus Physician’s Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum Bradley J. Monk , Rachel N. Grisham , Susana Banerjee , Elsa Kalbacher , Mansoor Raza Mirza , Ignacio Romero , Peter Vuylsteke , Robert L. Coleman , Felix Hilpert , Amit M. Oza , Anneke Westermann , Martin K. Oehler , Sandro Pignata , Carol Aghajanian , Nicoletta Colombo , Esther Drill , David Cibula , Kathleen N. Moore , Janna Christy-Bittel , Josep M. del Campo , Regina Berger , Christian Marth , Jalid Sehouli , David M. O'Malley , Cristina Churruca , Adam P. Boyd , Gunnar Kristensen , Andrew Clamp , Isabelle Ray-Coquard , Ignace Vergote Journal of clinical oncology（2020）
AI 理解论文
溯源树
样例
